Myung In Pharmaceutical LTD. (KRX:317450)

KRX:317450 Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	26,701	31,792	32,897	34,449	18,251	52,967
Short-Term Investments	443,301	477,901	227,399	153,080	124,434	67,786
Cash & Short-Term Investments	470,002	509,692	260,296	187,529	142,686	120,753
Cash Growth	69.15%	95.81%	38.80%	31.43%	18.16%	70.83%
Accounts Receivable	64,658	63,651	60,771	58,147	56,783	56,688
Other Receivables	5,727	5,055	3,492	3,711	2,710	2,138
Receivables	70,385	68,870	64,433	62,020	59,646	59,033
Inventory	78,005	64,108	60,343	56,277	47,880	46,732
Prepaid Expenses	578.13	538.02	510.71	434.13	533.52	243.22
Other Current Assets	1,245	100.97	225.49	1,329	72.68	176.49
Total Current Assets	620,216	643,309	385,809	307,589	250,818	226,938
Property, Plant & Equipment	141,908	118,513	99,259	99,309	103,706	110,187
Long-Term Investments	5	10,219	10,783	28,608	24,242	6,804
Other Intangible Assets	6,176	5,520	713.02	710.9	711.01	711.69
Long-Term Accounts Receivable	1,936	1,924	2,231	2,039	2,300	2,545
Long-Term Deferred Tax Assets	780.14	-	-	-	-	4.51
Other Long-Term Assets	97,405	61,943	82,717	83,119	89,528	82,344
Total Assets	868,426	841,675	581,692	521,590	471,556	429,760

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	9,401	6,301	8,298	2,397	2,129	2,245
Accrued Expenses	1,132	1,207	1,327	1,425	1,296	2,290
Current Portion of Leases	684.02	1,175	1,528	1,727	1,739	1,329
Current Income Taxes Payable	13,827	11,458	12,389	12,949	11,472	13,494
Current Unearned Revenue	7.67	17.32	-	-	-	-
Other Current Liabilities	24,963	26,026	21,059	20,686	18,458	20,374
Total Current Liabilities	50,015	46,184	44,602	39,184	35,093	39,732
Long-Term Leases	298.83	211.16	1,172	2,160	3,206	4,281
Long-Term Unearned Revenue	166.72	7.29	70.23	115.85	161.47	-
Pension & Post-Retirement Benefits	147.09	-	-	-	-	668.61
Long-Term Deferred Tax Liabilities	1.45	1.66	1,439	5,327	6,684	6,605
Other Long-Term Liabilities	1,431	892.39	2,589	2,489	2,432	2,382
Total Liabilities	52,060	47,297	49,871	49,276	47,577	53,668

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	7,300	7,300	5,600	5,600	5,600	5,600
Additional Paid-In Capital	192,082	192,082	-	-	-	-
Retained Earnings	627,524	602,371	533,269	471,701	421,245	373,297
Comprehensive Income & Other	-10,541	-7,375	-7,049	-4,988	-2,866	-2,805
Shareholders' Equity	816,365	794,378	531,821	472,314	423,979	376,092
Total Liabilities & Equity	868,426	841,675	581,692	521,590	471,556	429,760

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	982.84	1,386	2,700	3,887	4,945	5,609
Net Cash (Debt)	469,019	508,306	257,596	183,642	137,740	115,143
Net Cash Growth	70.08%	97.33%	40.27%	33.32%	19.63%	80.64%
Net Cash Per Share	33932.34	41931.84	22998.48	16396.62	12298.25	10280.65
Filing Date Shares Outstanding	14.6	14.6	11.2	11.2	11.2	11.2
Total Common Shares Outstanding	14.6	14.6	11.2	11.2	11.2	11.2
Working Capital	570,201	597,125	341,207	268,406	215,724	187,206
Book Value Per Share	55918.52	54409.46	47483.98	42170.89	37855.28	33579.64
Tangible Book Value	810,190	788,858	531,108	471,603	423,268	375,380
Tangible Book Value Per Share	55495.51	54031.38	47420.31	42107.41	37791.80	33516.10
Land	39,466	39,466	39,467	39,089	37,098	36,955
Buildings	59,273	59,273	59,179	59,291	59,020	58,923
Machinery	104,517	98,430	95,865	90,304	87,403	85,970
Construction In Progress	52,865	30,916	5,236	1,374	258.5	286.44

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 21, 2026

Data Sources Report a data error